BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8063036)

  • 1. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease.
    Wagner R; Genovese S; Bosi E; Becker F; Bingley PJ; Bonifacio E; Miles KA; Christie MR; Bottazzo GF; Gale EA
    Diabetologia; 1994 Apr; 37(4):365-71. PubMed ID: 8063036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.
    Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA
    Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies.
    Wagner R; McNally JM; Bonifacio E; Genovese S; Foulis A; McGill M; Christie MR; Betterle C; Bosi E; Bottazzo GF
    Diabetes; 1994 Jul; 43(7):851-6. PubMed ID: 7912208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
    Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
    Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
    Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
    Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.
    Seissler J; Hering B; Richter W; Glück M; Yassin N; Bretzel RG; Boehm BO; Federlin K; Scherbaum WA
    Diabetologia; 1992 Jun; 35(6):550-4. PubMed ID: 1612228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L; Delamaire M; Elmansour A; Maugendre D; Rohmer V; Joseph MG; Lecomte P; Limal JM; Charbonnel B; Allannic H
    Diabetologia; 1994 May; 37(5):491-9. PubMed ID: 8056187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
    Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
    Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
    Roll U; Christie MR; Standl E; Ziegler AG
    Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
    Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
    Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.